Evolution of MR Contrast Agents- Sponsored by GE HealthCare

Dr. Linda Chu sits down with Dr. Stephen Pomeranz, Dr. Gregory Connor, and Dr. Gautam Agrawal to explore the evolution of teleradiology from film-based workflows to today's highly connected remote reading environment. The panel discusses the impact of COVID on radiology practice, the importance of communication and clinical judgment, and how AI may reshape the future role of radiologists while enhancing patient care.  Sponsored by Vision Radiology

Dr. Refky Nicola speaks with Dr. Divya Kumari and Ashima Kundu about their analysis of more than three decades of malpractice payment data, revealing why diagnostic errors dominate radiology litigation and how outpatient care contributes to risk. They discuss practical strategies for trainees and institutions to reduce diagnostic failures, the impact of legal reforms, and how artificial intelligence may reshape malpractice exposure in the future.   Insights into Radiology Malpractice Cases in the United Statesfrom the National Practitioner Data Bank. Kundu et al. Radiology 2026; 320(2):e253352. 

Dr. Siddhant Dogra speaks with Dr. Ali Tejani about the essential AI literacy skills radiologists need to thrive in an era of foundation models, clinical AI tools, and rapidly evolving workflows. Together they explore AI education, model evaluation, human AI collaboration, workflow integration, and practical strategies for becoming a critical and informed user of radiology AI.   AI for Radiology: A Primer Part I. From Idea to Algorithm. Tejani et al. Radiology 2025; 317(1):e250692. AI for Radiology: A Primer Part II. Interacting with AI Results. Tejani et al. Radiology 2026; 320(1):e252702. 

Dr. Linda Chu welcomes Dr. Robert McDonald (Mayo Clinic) and Dr. Paul Evans (GE HealthCare) for a discussion on the evolution of MR contrast agents, exploring how gadolinium has changed MRI diagnostics and what decades of clinical experience have taught the radiology community. The conversation also looks ahead to emerging contrast technologies, including iron and manganese based agents and other innovations that could shape the future of MR imaging, safety, and sustainability. Sponsored by GE HealthCare  

Dr. Reni Butler speaks with Dr. Bryan Haslam, Dr. Greg Sorensen, Dr. Matt McCabe, and Dr. Christoph Lee about their large real-world study evaluating an AI driven workflow for screening mammography across 109 U.S. facilities. Together, they explore how AI helped general radiologists achieve cancer detection and recall performance comparable to breast imaging specialists, as well as the broader implications for patient care, workflow design, and the future of precision screening. Closing the Performance Gap between Generalists and BreastImaging Specialists Using a Nationally Deployed AI Workflowfor Screening Mammography. McCabe et al. Radiology 2026; 320(1):e252005. 

Host Dr. Linda Chu sits down with Dr. Jie Nguyen, Dr. Todd Lawrence, and Dr. Kirk Davis to discuss an interdisciplinary consensus on standardized knee meniscus MRI reporting and the terminology that improves communication between radiologists and orthopedic surgeons. Together, they explore MRI criteria for meniscus tears, reporting best practices, surgical implications, post operative assessment, and how consistent language can enhance patient care and clinical decision making. Standardized Knee Meniscus MRI Reporting: An Interdisciplinary Delphi Consensus. Nguyen et al. Radiology 2026; 319(3):e251833.   Sponsored by GE HealthCare

Dr. Ashwin Parihar speaks with Dr. Olayinka A. Abiodun-Ojo and Dr. David M. Schuster about findings from the EMPIRE 2 trial, exploring how fluciclovine PET and PSMA PET influence salvage radiotherapy planning for men with recurrent prostate cancer after prostatectomy. The discussion examines the strengths and limitations of each tracer, the importance of prostate bed detection, and where fluciclovine may still have a role in the evolving era of PSMA-targeted imaging. 18F-Fluciclovine or 68Ga-PSMA-11 PET/CT–guided SalvageRadiotherapy Changes in Postprostatectomy BiochemicalRecurrence: Secondary Analysis of the EMPIRE-2 Trial. Abiodun-Ojo and Jani et al. Radiology 2026; 319(3):e251874. 

In this episode of the Radiology Podcast, Dr. Siddhant Dogra speaks with Dr. Albert Jiao about Radiology Reimagined and the critical role interoperability plays in integrating AI into everyday radiology workflows. Together, they explore lessons learned from large-scale AI demonstrations, practical considerations for evaluating imaging AI tools, and what the future of radiology innovation may look like. Radiology Reimagined: Interoperability and Lessons Learned from the Imaging AI in Practice Demonstration. Jiao et al. Radiology 2026; 319(3):e252225.

Dr. Lauren Kim speaks with first author Dr. Andrew Hernandez about his study which comprehensively quantified energy consumption in MRI, CT, and PET/CT imaging suites by measuring the energy utilization of main power, HVAC, and chilled water subsystems. The study showed that HVAC and chilled water subsystems contribute substantially to total energy consumption, that energy efficiency increases with increasing daily scanning volume, and that a substantial portion of energy consumption occurs during non-operating hours.   Quantification of Imaging Suite–Level Energy Patterns in MRI, CT, and PET/CT to Guide Energy Efficiency. Hernandez et al. Radiology 2026; 319(1):e253128.

Host Dr. Reni Butler sits down with Dr. Connie Lehman to discuss groundbreaking research on how AI-generated breast cancer risk scores change over time and what those changes may reveal about a woman's future cancer risk. Together, they explore the promise of longitudinal imaging biomarkers, personalized screening strategies, and how artificial intelligence could transform breast cancer detection and prevention. Longitudinal Analysis of Changes in Deep Learning Image-based Breast Cancer Risk Scores over Time. Lehman et al. Radiology 2026; 319(3):e253023.